Summit Therapeutics Inc. (SMMT) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Summit Therapeutics Inc.

    NASDAQ: SMMT · Real-Time Price · USD
    21.43
    0.56 (2.68%)
    At close: Oct 03, 2025, 3:59 PM

    Summit Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -57.95 -2.63 -10.43 -2.8
    PEG Ratio
    		 0.84 -0.02 0.18 -0.11
    PS Ratio
    		 n/a n/a 1.17K 137.16
    PB Ratio
    		 32.99 20.82 6.49 2.98
    P/FCF Ratio
    		 -90.17 -21.03 -19.47 -3.4
    P/OCF Ratio
    		 -90.26 -21.07 -19.76 -3.42
    OCF/S Ratio
    		 n/a n/a -59.04 -40.13
    Debt / Equity Ratio
    		 0.02 1.37 4.10 0.03
    Quick Ratio
    		 10.15 9.30 9.16 3.52
    Current Ratio
    		 10.15 9.30 16.93 3.80
    Asset Turnover
    		 n/a n/a 0.00 0.02
    Interest Coverage
    		 0.04 -5.45 -13.55 -306.71
    Return on Equity
    		 -0.57 -7.91 -0.62 -1.06
    Return on Assets
    		 -0.51 -3.03 -0.12 -0.78
    Return on Invested Capital
    		 n/a -0.48 -0.09 -0.97
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a -2.57 1.00
    Net Profit Margin
    		 n/a n/a -111.86 -48.98
    Pretax Profit Margin
    		 n/a n/a -111.86 -48.98
    Operating Profit Margin
    		 n/a n/a -84.67 -47.64
    FCF Margin
    		 n/a n/a -59.93 -40.29
    EBITDA Margin
    		 n/a n/a -103.82 -47.49

    Add to Watchlist